Prokidney (PROK) Profit After Tax (2021 - 2026)
Prokidney's (PROK) quarterly Profit After Tax came in at -$42.6 million in Q1 2026, down 12.3% year-on-year from -$48.6 million in Q1 2025, and down 4.33% on a QoQ basis from -$40.9 million in Q4 2025.
Prokidney (PROK) Profit After Tax (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Profit After Tax data on file, last reported at -$42.6 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 12.3% year-over-year to -$42.6 million in Q1 2026; TTM through Mar 2026 was -$156.3 million, a 5.83% increase from a year earlier, with the FY2025 full-year figure at -$151.6 million, up 7.18% from the prior year.
- Profit After Tax for Q1 2026 stood at -$42.6 million, down from -$40.9 million in the prior quarter.
- Over the last five years, Profit After Tax for PROK reached as high as $78.3 million in Q4 2023 and fell as low as -$67.5 million in Q1 2022.
- Historically, Profit After Tax has averaged -$33.4 million across 5 years, with a median of -$38.0 million in 2025.
- Across the five-year window, Profit After Tax tumbled 415505.63% in 2022 and soared 243.58% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$54.5 million in 2022, then surged by 243.58% to $78.3 million in 2023, then tumbled by 161.96% to -$48.5 million in 2024, then climbed by 15.74% to -$40.9 million in 2025, then decreased by 4.33% to -$42.6 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$42.6 million in Q1 2026, -$40.9 million in Q4 2025, and -$35.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -42.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.62 Mn |
| Dec 31, 2025 | -40.85 Mn |
| Sep 30, 2025 | -35.84 Mn |
| Jun 30, 2025 | -36.97 Mn |
| Mar 31, 2025 | -37.95 Mn |
| Dec 31, 2024 | -48.48 Mn |
| Sep 30, 2024 | -41.05 Mn |
| Jun 30, 2024 | -38.47 Mn |
| Mar 31, 2024 | -35.33 Mn |
| Dec 31, 2023 | 78.26 Mn |
| Sep 30, 2023 | -41.99 Mn |
| Jun 30, 2023 | -34.82 Mn |
| Mar 31, 2023 | -36.91 Mn |
| Dec 31, 2022 | -54.50 Mn |
| Sep 30, 2022 | -29.93 Mn |
| Jun 30, 2022 | -22.13 Mn |
| Mar 31, 2022 | -67.49 Mn |
| Dec 31, 2021 | -2.32 Mn |
| Sep 30, 2021 | -17.14 Mn |
| Jun 30, 2021 | -5,325.00 |